The Hawaii Headache & Facial Pain Center and Hawaii Headache Research Unit have been awarded a clinical research study to investigate XEOMIN® (incobotulinumtoxinA) as a potential preventive treatment for chronic and episodic migraine. This important research initiative aims to address…
The American Academy of Neurology (AAN) official continuing medical education journal, Continuum: Lifelong Learning in Neurology®, has referenced research conducted by University of Hawaiʻi John A. Burns School of Medicine (JABSOM) neurologists and former medical students in its June 2025…
The American Academy of Neurology (AAN) official continuing medical education journal, Continuum: Lifelong Learning in Neurology®, has referenced research conducted by University of Hawaiʻi John A. Burns School of Medicine (JABSOM) neurologists and former medical students in its February 2025…
ERP Biomarkers of Cognitive Dysfunction in Alzheimer’s Disease: Real-World Evidence Supporting Translational Clinical Trial Endpoints Advances in neuroscience and digital biomarkers are transforming how clinicians and researchers detect, monitor, and study Alzheimer’s disease (AD). At the 2025 Clinical Trials on…
The Hawaii ALS and Neuromuscular Center has been selected to participate in the ADAPT-EARLY clinical trial, a Phase 4 research study evaluating efgartigimod PH20 SC in adults with new-onset generalized myasthenia gravis (gMG). This important study focuses on early treatment…
Brainshuttle™ Launched in Hawaii! Novel Alzheimer’s Drug Trontinemab with Brainshuttle™ Technology A new Alzheimer’s clinical study using the investigational drug trontinemab, engineered with Brainshuttle™ technology, is now accepting participants in Hawaii. This approach aims to achieve rapid amyloid clearance with…
RECENT BLOGS
-
Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience
-
Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors
-
Dr. Kore Kai Liow Named 2026 Hawaii Physician of the Year | HPN
-
University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease
-
A Triple Burden In Native Hawaiian And Pacific Islander Patients With Epilepsy: The Cardiometabolic Risks Of Obesity, Diabetes, Smoking, And Their Association With Seizure Control
-
2026 Hawaii Comprehensive Epilepsy Ctr & Epilepsy Research Unit in Hawaii Awarded Study to Investigate Novel anti-Galectin-3 monoclonal Antibody for the Drug-Resistant Epilepsy (DRE)
-
Hawaii Selected to Investigate Povetacicept for Myasthenia Gravis
-
Assessing the Understanding of Neurological Conditions in Young Adults and Leveraging Media Outlets and Social Media Platforms for Neurology Awareness
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED